IP Library Patent Application 11757620
Patent Application
App. No. 11/757,620

EXPRESSION QUANTIFICATION USING MASS SPECTROMETRY

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/757,620
Abstract

In various aspects, the present teachings provide systems, methods, assays and kits for the absolute quantitation of protein expression. In various aspects, the present teachings provide methods of determining the concentration of about the top forty-one proteins present in human plasma. In various aspects, the present teachings provide methods of determining the absolute concentration of one or more proteins using standard samples of signature protein fragments and parent-daughter ion transition monitoring (PDITM). In various embodiments, the absolute concentration of multiple isoforms of a biomolecule in a sample, multiple proteins in a biological process, a combination of multiple samples, or combinations thereof, can be determined in a multiplex fashion using the present teachings. In various aspects, provided are methods of assessing the state of a biological system including, but not limited to, the disease state of an animal.

Claims (30)

1 . A method for assessing the biological state of a sample, comprising the steps of:

providing a standard sample comprising a signature peptide for each protein of interest;

selecting a diagnostic daughter ion for each signature peptide;

labeling the one or more proteins of interest in two or more samples of interest with different chemical moieties for each sample, the two or more samples of interest thereby being differentially labeled;

labeling one or more standard samples with a chemical moiety;

combining, to produce a combined sample, at least a portion of the one or more labeled standard samples with at least a portion of two or more differentially labeled samples, the differentially labeled samples being labeled with a different chemical moiety than the one or more labeled standard samples combined therewith;

loading at least a portion of the combined sample on a chromatographic column;

subjecting at least a portion of the eluent from the chromatographic column to multiple reaction monitoring, the transmitted parent ion m/z range of each multiple reaction monitoring scan including a m/z value of one or more of the labeled signature peptides and the transmitted daughter ion m/z range of each multiple reaction monitoring scan including a m/z value one or more of the selected diagnostic daughter ions corresponding to the transmitted labeled signature peptide;

measuring the ion signal of one or more of the selected diagnostic daughter ions using said multiple reaction monitoring; and

determining the concentration of a protein of interest in one or more of the two or more samples of interest based at least on a comparison of the measured ion signal of a selected diagnostic daughter ion corresponding to the protein of interest from a sample of interest to the measured ion signal for the selected diagnostic daughter ion corresponding to the protein of interest from a labeled standard sample; and

assessing the biological state of the sample based at least on a comparison of the relative concentrations of two or more proteins in one or more of the two or more samples to the concentration of two or more corresponding proteins in one or more of the standard samples; wherein

the one or more proteins of interest are one or more of the proteins listed in column 1 of Table 4; and further wherein

the signature peptide comprises one or more of the peptides listed in column 3 of Table 4, which corresponds to a respective protein of interest listed in column 1 of Table 4.

2 . The method of claim 1 , wherein the step of labeling proteins of interest in one or more standard samples comprises labeling proteins of interest with an isotopically coded affinity tag, and wherein the step of labeling proteins of interest in different samples comprises labeling proteins of interest with an isotopically coded affinity tag.

3 . The method of claim 1 , wherein the step of labeling proteins of interest in one or more standard samples comprises labeling proteins of interest with an isobaric tag, and wherein the step of labeling proteins of interest in different samples comprises labeling proteins of interest with an isobaric tag.

4 . The method of claim 1 , wherein the step of labeling proteins of interest in one or more standard samples comprises labeling proteins of interest with a mass differential tag, and wherein the step of labeling proteins of interest in different samples comprises labeling proteins of interest with a mass differential tag.

5 . The method of claim 1 , wherein the one or more standard samples comprise a pooled reference sample.

6 . The method of claim 1 , further comprising the step of subjecting at least a portion of the combined sample to digestion to produce a digested combined sample prior to loading of at least a portion of the combined sample on a chromatographic column, and wherein the portion of the combined sample on a chromatographic column is all or a portion of the digested combined sample.

7 . The method of claim 6 , wherein the digestion comprises chemical digestion.

8 . The method of claim 6 , wherein the digestion comprises enzymatic digestion.

9 . The method of claim 1 , wherein one or more of the one or more of the standard samples are subjected to a digestion prior to being combined with the two or more labeled samples of interest to produce a combined sample.

10 . The method of claim 9 , wherein the digestion comprises chemical digestion.

11 . The method of claim 9 , wherein the digestion comprises enzymatic digestion.

12 . The method of claim 1 , wherein the step of determining the concentration of a protein of interest comprises determining the absolute concentration of the protein of interest.

13 . The method of claim 1 , the step of determining the concentration of a protein of interest comprises determining the relative concentration of the protein of interest, wherein the labeled standard sample comprises a pooled reference sample.

14 . The method of claim 1 , wherein the step of assessing the biological state of a sample comprises a comparison based at least on a comparison of the absolute concentrations of two or more proteins in one or more of the two or more samples to the concentration of two or more corresponding proteins in one or more of the standard samples.

15 . The method of claim 1 , wherein the biological state comprises one or more of a disease state, a response to a chemical agent, or combinations thereof.

16 . The method of claim 1 , wherein:

the transmitted parent ion m/z range of each multiple reaction monitoring scan for a protein of interest listed in column 1 of Table 4 includes an m/z value listed in column 6 of Table 4, which corresponds to a respective signature peptide listed in column 3 of Table 4, which corresponds to a respective protein of interest listed in column 1 of Table 4; and

the transmitted diagnostic daughter ion m/z range of each multiple reaction monitoring scan for a protein of interest listed in column 1 of Table 4 includes an m/z value listed in column 7 of Table 4, which corresponds to a respective parent ion m/z value listed in column 6 of Table 4, which corresponds to a respective signature peptide listed in column 3 of Table 4, which corresponds to a respective protein of interest listed in column 1 of Table 4.

Assignments (8)
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY NAME PREVIOUSLY RECORDED AT REEL: 030182 FRAME: 0677. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Mar 7, 2016
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 038026/0001 →
LIEN RELEASE Recorded Apr 9, 2013
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, INC.
Reel/Frame 030182/0677 →
RELEASE OF SECURITY INTEREST Recorded Mar 31, 2010
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 024160/0955 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2010
From: APPLIED BIOSYSTEMS, LLC
To: DH TECHNOLOGIES PTE. LTD.
Reel/Frame 023937/0854 →
CHANGE OF NAME Recorded Nov 6, 2009
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 023479/0923 →
MERGER Recorded Nov 6, 2009
From: APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 023479/0932 →
SECURITY AGREEMENT Recorded Dec 5, 2008
From: APPLIED BIOSYSTEMS, LLC
To: BANK OF AMERICA, N.A, AS COLLATERAL AGENT
Reel/Frame 021976/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2008
From: HUNTER, CHRISTIE L.
To: APPLERA CORPORATION
Reel/Frame 020862/0701 →